{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "26194509-66fb-4e01-b3c6-47c7952a13c3",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\anaconda3\\envs\\llms\\Lib\\site-packages\\langchain_core\\_api\\deprecation.py:26: UserWarning: Core Pydantic V1 functionality isn't compatible with Python 3.14 or greater.\n",
      "  from pydantic.v1.fields import FieldInfo as FieldInfoV1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Consider using the pymupdf_layout package for a greatly improved page layout analysis.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\anaconda3\\envs\\llms\\Lib\\site-packages\\urllib3\\connectionpool.py:1097: InsecureRequestWarning: Unverified HTTPS request is being made to host 'ngw.devices.sberbank.ru'. Adding certificate verification is strongly advised. See: https://urllib3.readthedocs.io/en/latest/advanced-usage.html#tls-warnings\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.document_loaders import PyMuPDFLoader\n",
    "from pydantic import BaseModel, Field\n",
    "from langchain_core.output_parsers import PydanticOutputParser, StrOutputParser, BaseOutputParser\n",
    "from textwrap import dedent\n",
    "\n",
    "from langchain_openai import ChatOpenAI\n",
    "from langchain_core.messages import HumanMessage\n",
    "from langchain_core.prompts import ChatPromptTemplate\n",
    "import httpx\n",
    "import json\n",
    "import requests\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re\n",
    "\n",
    "from langchain_pymupdf4llm import PyMuPDF4LLMLoader, PyMuPDF4LLMParser\n",
    "import pymupdf4llm\n",
    "import requests\n",
    "import uuid\n",
    "from openai import OpenAI\n",
    "\n",
    "import time\n",
    "import os\n",
    "from dotenv import load_dotenv, find_dotenv\n",
    "\n",
    "load_dotenv(find_dotenv(usecwd=True))\n",
    "\n",
    "BASE_URL = \"https://gigachat.devices.sberbank.ru/api/v1\"\n",
    "#base_gg = \"https://router.huggingface.co/v1\"\n",
    "#\"http://a6k2.dgx:34000/v1\"\n",
    "\n",
    "BASE_URL = \"https://router.huggingface.co/v1\"\n",
    "\n",
    "#\"qwen3-32b\"\n",
    "# gigachat/GigaChat\n",
    "MODEL_NAME = os.getenv(\"MODEL_NAME\", 'GigaChat')\n",
    "\n",
    "\n",
    "\n",
    "MODEL_NAME_HF ='meta-llama/Llama-3.3-70B-Instruct'\n",
    "MODEL_NAME_HF ='Qwen/Qwen3-32B'\n",
    "\n",
    "MODEL_TEMPERATURE_HF =1\n",
    "\n",
    "os.environ[\"BASE_URL\"] = \"https://gigachat.devices.sberbank.ru/api/v1\"\n",
    "os.environ[\"MODEL_NAME\"] ='GigaChat'\n",
    "#os.environ[\"OPENAI_API_KEY\"] = os.getenv(\"GIGACHAT_AUTH\")\n",
    "\n",
    "os.environ['TEMPERATURE'] = '0'\n",
    "\n",
    "url = \"https://ngw.devices.sberbank.ru:9443/api/v2/oauth\"\n",
    "# Создадим идентификатор UUID (36 знаков)\n",
    "rq_uid = str(uuid.uuid4())\n",
    "payload={\n",
    "  'scope': 'GIGACHAT_API_PERS'\n",
    "}\n",
    "headers = {\n",
    "  'Content-Type': 'application/x-www-form-urlencoded',\n",
    "  'Accept': 'application/json',\n",
    "  'RqUID': rq_uid,\n",
    "  'Authorization': f'Basic {os.getenv(\"GIGACHAT_AUTH\")}'\n",
    "}\n",
    "\n",
    "response = requests.request(\"POST\", url, headers=headers, data=payload, verify=False)\n",
    "os.environ[\"OPENAI_API_KEY\"] = response.json()['access_token']\n",
    "\n",
    "\n",
    "from trialmind.pubmed import pmid2papers, PubmedAPIWrapper, pmid2biocxml, parse_bioc_xml\n",
    "from trialmind.api import StudyCharacteristicsExtraction, ScreeningCriteriaGeneration,LiteratureScreening\n",
    "from trialmind.retrievers import split_text_into_chunks\n",
    "import extract\n",
    "\n",
    "%load_ext autoreload\n",
    "%autoreload 2\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5301994a-a15c-47ce-b6b8-ce0ceae9e67b",
   "metadata": {
    "tags": []
   },
   "source": [
    "### clinical trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "7eb1ed4e-88ad-454d-a841-868d8d03925b",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('Colorectal cancer',\n",
       " ['Crizotinib',\n",
       "  'Loratinib',\n",
       "  'Necitumumab',\n",
       "  'Nimotuzumab',\n",
       "  'Panitumumab',\n",
       "  'Cetuximab',\n",
       "  'Brigatinib',\n",
       "  'Ramucirumab',\n",
       "  'Pomalidomide',\n",
       "  'Tamoxifen',\n",
       "  'Denosumab',\n",
       "  'Duvelisib',\n",
       "  'Inavilisib',\n",
       "  'Bevacizumab',\n",
       "  'Anastrozole',\n",
       "  'Exemestane'])"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "file_path = \"docs/CC_215_L00_DL_fusion_fixed_oncobox_ru.pdf\"\n",
    "fin_condition, treatements_eng = extract.info_from_doc(file_path)\n",
    "fin_condition, treatements_eng"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e3c68437-54be-4611-9aa0-d7f6a379a924",
   "metadata": {},
   "source": [
    "1. загрузить док\n",
    "2. взять 1-ую страницу; рег.выражениями взять диагноз\n",
    "-- с ЛЛМ перевести на англ.\n",
    "3. найти страницу с таблицей; или взять таблицы с PyMuPDFLoader\n",
    "4. извлечь таблицу"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e04c59f8-3cbd-4491-9154-56edbc434e12",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Crizotinib OR Loratinib OR Necitumumab OR Nimotuzumab OR Panitumumab OR Cetuximab OR Brigatinib OR Ramucirumab OR Pomalidomide OR Tamoxifen OR Denosumab OR Duvelisib OR Inavilisib OR Bevacizumab OR Anastrozole OR Exemestane'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "' OR '.join(treatements_eng)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "6b530143-823c-495a-8e2a-7039031a23b2",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('Cetuximab', '\"Colorectal cancer\"')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "treatements_eng[5], f'''\"{fin_condition}\"'''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "0b55cf5c-e883-4a42-ad8f-08633873be8f",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ZVNj7o2Elu8o3lppXcuzsbrumpOQJJxsYfWj3_g\n",
      "ZVNj7o2Elu8o3lppXcuzsbrumpOQJJxobPKj1fg\n",
      "ZVNj7o2Elu8o3lppXcuzsbrumpOQJJxmYvGg3fg\n",
      "ZVNj7o2Elu8o3lppXcuzsbrumpOQJJxuZ_Cg3_AW\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>results</th>\n",
       "      <th>id</th>\n",
       "      <th>title</th>\n",
       "      <th>status</th>\n",
       "      <th>conditions</th>\n",
       "      <th>study_type</th>\n",
       "      <th>phases</th>\n",
       "      <th>interventions</th>\n",
       "      <th>outcomes</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT06959589</td>\n",
       "      <td>The Efficacy and Safety of IBI351, Cetuximab β...</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>[Colorectal Cancer Metastatic, KRAS G12C Mutat...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[ibi351, cetuximab β combined with folfiri]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT02484833</td>\n",
       "      <td>Erbitux MEtastatic Colorectal Cancer Strategy ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Antineoplastic Agents]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE3]</td>\n",
       "      <td>[cetuximab, folfiri]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT06358430</td>\n",
       "      <td>Dose Escalation and Expansion Study of TROP2 C...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>[Colorectal Cancer, Minimal Residual Disease]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE1]</td>\n",
       "      <td>[fludarabine phosphate, cyclophosphamide, cetu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT00703976</td>\n",
       "      <td>Radiation, Cetuximab and Pemetrexed With or Wi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[bevacizumab, cetuximab, pemetrexed]</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': '2-year Progress...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT00835679</td>\n",
       "      <td>Cetuximab and/or Dasatinib in Patients With Co...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>[Liver Metastases, Mucinous Adenocarcinoma of ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[EARLY_PHASE1]</td>\n",
       "      <td>[dasatinib]</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Patients With a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT00719199</td>\n",
       "      <td>Study of FOLFIRI Plus Cetuximab Plus IMO-2055 ...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>[Colorectal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE1]</td>\n",
       "      <td>[imo-2055, cetuximab, folfiri]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT04513951</td>\n",
       "      <td>AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Metastatic Colorectal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[5fluorouracil, l-leucovorin, irinotecan, oxal...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT06856187</td>\n",
       "      <td>Second-line Standard Treatment Sequential TAS-...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>[Metastatic Colorectal Cancer (CRC)]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[tas-102+bevacizumab+local treatment, standard...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT01167725</td>\n",
       "      <td>Standard Therapy With or Without Surgery and M...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>[Colorectal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE3]</td>\n",
       "      <td>[folfiri regimen, folfox regimen, capecitabine...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT02029326</td>\n",
       "      <td>Biomarker Analysis in Metastatic Colorectal Ca...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Colorectal Cancer]</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT00910676</td>\n",
       "      <td>Study About Preventive Treatment of Folliculit...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Metastatic Colorectal Cancer, Non-Small-Cell ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[diprosone]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT01787006</td>\n",
       "      <td>Definitive Radiochemotherapy Plus/Minus Cetuxi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Esophageal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[cetuximab, cisplatin, 5-fu]</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Rate of Partici...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT06412198</td>\n",
       "      <td>A Multicenter Phase 1b/2 Study of Adagrasib, C...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>[Metastatic Colorectal Cancer, KRAS G12C Mutat...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE1, PHASE2]</td>\n",
       "      <td>[cetuximab, cemiplimab, adagrasib]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT05253651</td>\n",
       "      <td>A Study of Tucatinib With Trastuzumab and mFOL...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>[Colorectal Neoplasms]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE3]</td>\n",
       "      <td>[tucatinib, trastuzumab, bevacizumab, cetuxima...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT00541112</td>\n",
       "      <td>Radiation Therapy, Chemotherapy, and Cetuximab...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>[Colorectal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[capecitabine, fluorouracil, leucovorin calciu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>False</td>\n",
       "      <td>NCT00743678</td>\n",
       "      <td>Neoadjuvant FOLFOX6 + Cetuximab in Patients Wi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Colorectal Cancer, Unresectable Liver Metasta...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[folfox6/cetuximab]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    results           id                                              title  \\\n",
       "0     False  NCT06959589  The Efficacy and Safety of IBI351, Cetuximab β...   \n",
       "1     False  NCT02484833  Erbitux MEtastatic Colorectal Cancer Strategy ...   \n",
       "2     False  NCT06358430  Dose Escalation and Expansion Study of TROP2 C...   \n",
       "3      True  NCT00703976  Radiation, Cetuximab and Pemetrexed With or Wi...   \n",
       "4      True  NCT00835679  Cetuximab and/or Dasatinib in Patients With Co...   \n",
       "5     False  NCT00719199  Study of FOLFIRI Plus Cetuximab Plus IMO-2055 ...   \n",
       "6     False  NCT04513951  AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initi...   \n",
       "7     False  NCT06856187  Second-line Standard Treatment Sequential TAS-...   \n",
       "8     False  NCT01167725  Standard Therapy With or Without Surgery and M...   \n",
       "9     False  NCT02029326  Biomarker Analysis in Metastatic Colorectal Ca...   \n",
       "10    False  NCT00910676  Study About Preventive Treatment of Folliculit...   \n",
       "11     True  NCT01787006  Definitive Radiochemotherapy Plus/Minus Cetuxi...   \n",
       "12    False  NCT06412198  A Multicenter Phase 1b/2 Study of Adagrasib, C...   \n",
       "13    False  NCT05253651  A Study of Tucatinib With Trastuzumab and mFOL...   \n",
       "14    False  NCT00541112  Radiation Therapy, Chemotherapy, and Cetuximab...   \n",
       "15    False  NCT00743678  Neoadjuvant FOLFOX6 + Cetuximab in Patients Wi...   \n",
       "\n",
       "                status                                         conditions  \\\n",
       "0   NOT_YET_RECRUITING  [Colorectal Cancer Metastatic, KRAS G12C Mutat...   \n",
       "1            COMPLETED                            [Antineoplastic Agents]   \n",
       "2           RECRUITING      [Colorectal Cancer, Minimal Residual Disease]   \n",
       "3            COMPLETED                                           [Cancer]   \n",
       "4           TERMINATED  [Liver Metastases, Mucinous Adenocarcinoma of ...   \n",
       "5           TERMINATED                                [Colorectal Cancer]   \n",
       "6            COMPLETED                     [Metastatic Colorectal Cancer]   \n",
       "7           RECRUITING               [Metastatic Colorectal Cancer (CRC)]   \n",
       "8           TERMINATED                                [Colorectal Cancer]   \n",
       "9            COMPLETED                                [Colorectal Cancer]   \n",
       "10           COMPLETED  [Metastatic Colorectal Cancer, Non-Small-Cell ...   \n",
       "11           COMPLETED                                [Esophageal Cancer]   \n",
       "12          RECRUITING  [Metastatic Colorectal Cancer, KRAS G12C Mutat...   \n",
       "13          RECRUITING                             [Colorectal Neoplasms]   \n",
       "14          TERMINATED                                [Colorectal Cancer]   \n",
       "15           COMPLETED  [Colorectal Cancer, Unresectable Liver Metasta...   \n",
       "\n",
       "        study_type            phases  \\\n",
       "0   INTERVENTIONAL          [PHASE2]   \n",
       "1   INTERVENTIONAL          [PHASE3]   \n",
       "2   INTERVENTIONAL          [PHASE1]   \n",
       "3   INTERVENTIONAL          [PHASE2]   \n",
       "4   INTERVENTIONAL    [EARLY_PHASE1]   \n",
       "5   INTERVENTIONAL          [PHASE1]   \n",
       "6   INTERVENTIONAL          [PHASE2]   \n",
       "7   INTERVENTIONAL          [PHASE2]   \n",
       "8   INTERVENTIONAL          [PHASE3]   \n",
       "9    OBSERVATIONAL               NaN   \n",
       "10  INTERVENTIONAL          [PHASE2]   \n",
       "11  INTERVENTIONAL          [PHASE2]   \n",
       "12  INTERVENTIONAL  [PHASE1, PHASE2]   \n",
       "13  INTERVENTIONAL          [PHASE3]   \n",
       "14  INTERVENTIONAL          [PHASE2]   \n",
       "15  INTERVENTIONAL          [PHASE2]   \n",
       "\n",
       "                                        interventions  \\\n",
       "0         [ibi351, cetuximab β combined with folfiri]   \n",
       "1                                [cetuximab, folfiri]   \n",
       "2   [fludarabine phosphate, cyclophosphamide, cetu...   \n",
       "3                [bevacizumab, cetuximab, pemetrexed]   \n",
       "4                                         [dasatinib]   \n",
       "5                      [imo-2055, cetuximab, folfiri]   \n",
       "6   [5fluorouracil, l-leucovorin, irinotecan, oxal...   \n",
       "7   [tas-102+bevacizumab+local treatment, standard...   \n",
       "8   [folfiri regimen, folfox regimen, capecitabine...   \n",
       "9                                                  []   \n",
       "10                                        [diprosone]   \n",
       "11                       [cetuximab, cisplatin, 5-fu]   \n",
       "12                 [cetuximab, cemiplimab, adagrasib]   \n",
       "13  [tucatinib, trastuzumab, bevacizumab, cetuxima...   \n",
       "14  [capecitabine, fluorouracil, leucovorin calciu...   \n",
       "15                                [folfox6/cetuximab]   \n",
       "\n",
       "                                             outcomes  \n",
       "0                                                 NaN  \n",
       "1                                                 NaN  \n",
       "2                                                 NaN  \n",
       "3   [{'type': 'PRIMARY', 'title': '2-year Progress...  \n",
       "4   [{'type': 'PRIMARY', 'title': 'Patients With a...  \n",
       "5                                                 NaN  \n",
       "6                                                 NaN  \n",
       "7                                                 NaN  \n",
       "8                                                 NaN  \n",
       "9                                                 NaN  \n",
       "10                                                NaN  \n",
       "11  [{'type': 'PRIMARY', 'title': 'Rate of Partici...  \n",
       "12                                                NaN  \n",
       "13                                                NaN  \n",
       "14                                                NaN  \n",
       "15                                                NaN  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_studies = extract.get_clinicaltrials(f'''\"{fin_condition}\"''', \n",
    "                                      #' OR '.join(treatements_eng), \n",
    "                                       treatements_eng[5],  \n",
    "                                      max_studies=4)\n",
    "all_studies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "73f7c7c5-3482-42cc-8a07-208dd8b9f1e0",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\AppData\\Local\\Temp\\ipykernel_3488\\2348048961.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x \\\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(3, 10)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chosen = all_studies[all_studies.results==True]\n",
    "chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x \\\n",
    "                                                           if(obj.get('unitOfMeasure','').lower() in ['percentage of participants','participants'])])\n",
    "chosen.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "94f8a4dc-a143-4a59-8e9a-fcbebc3542bb",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['hasResults',\n",
       " 'nctId',\n",
       " 'briefTitle',\n",
       " 'overallStatus',\n",
       " 'briefSummary',\n",
       " 'conditions',\n",
       " 'studyType',\n",
       " 'interventions']"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[i.split('.')[-1] for i in all_studies.columns]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "8bf4c7f2-ff10-4103-bcc2-477a65e2c6d5",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ZVNj7o2Elu8o3lppWovzpbrumpOQJJxmZ_Wp\n",
      "ZVNj7o2Elu8o3lppWovzpbrumpOQJJxsZ_at0A\n",
      "Index(['hasResults', 'protocolSection.identificationModule.nctId',\n",
      "       'protocolSection.identificationModule.briefTitle',\n",
      "       'protocolSection.statusModule.overallStatus',\n",
      "       'protocolSection.descriptionModule.briefSummary',\n",
      "       'protocolSection.conditionsModule.conditions',\n",
      "       'protocolSection.designModule.studyType',\n",
      "       'protocolSection.designModule.phases',\n",
      "       'protocolSection.armsInterventionsModule.interventions',\n",
      "       'resultsSection.outcomeMeasuresModule.outcomeMeasures'],\n",
      "      dtype='object')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>hasResults</th>\n",
       "      <th>nctId</th>\n",
       "      <th>briefTitle</th>\n",
       "      <th>overallStatus</th>\n",
       "      <th>briefSummary</th>\n",
       "      <th>conditions</th>\n",
       "      <th>studyType</th>\n",
       "      <th>phases</th>\n",
       "      <th>interventions</th>\n",
       "      <th>outcomeMeasures</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT03563157</td>\n",
       "      <td>QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>QUILT 3.071 NANT Colorectal Cancer (CRC) Vacci...</td>\n",
       "      <td>[Colorectal Cancer Metastatic, mCRC]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE1, PHASE2]</td>\n",
       "      <td>[{'type': 'BIOLOGICAL', 'name': 'Aldoxorubicin...</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Number of Parti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT00321100</td>\n",
       "      <td>Combination of Cetuximab, Capecitabine, and Ox...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this study is to determine the ...</td>\n",
       "      <td>[Colorectal Neoplasms]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[{'type': 'DRUG', 'name': 'bevacizumab', 'desc...</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Objective Respo...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   hasResults        nctId                                         briefTitle  \\\n",
       "0        True  NCT03563157  QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine   \n",
       "1        True  NCT00321100  Combination of Cetuximab, Capecitabine, and Ox...   \n",
       "\n",
       "  overallStatus                                       briefSummary  \\\n",
       "0    TERMINATED  QUILT 3.071 NANT Colorectal Cancer (CRC) Vacci...   \n",
       "1    TERMINATED  The purpose of this study is to determine the ...   \n",
       "\n",
       "                             conditions       studyType            phases  \\\n",
       "0  [Colorectal Cancer Metastatic, mCRC]  INTERVENTIONAL  [PHASE1, PHASE2]   \n",
       "1                [Colorectal Neoplasms]  INTERVENTIONAL          [PHASE2]   \n",
       "\n",
       "                                       interventions  \\\n",
       "0  [{'type': 'BIOLOGICAL', 'name': 'Aldoxorubicin...   \n",
       "1  [{'type': 'DRUG', 'name': 'bevacizumab', 'desc...   \n",
       "\n",
       "                                     outcomeMeasures  \n",
       "0  [{'type': 'PRIMARY', 'title': 'Number of Parti...  \n",
       "1  [{'type': 'PRIMARY', 'title': 'Objective Respo...  "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "base = 'https://clinicaltrials.gov/api/v2/studies'  # new API\n",
    "\n",
    "# fields for CSV and JSON: https://clinicaltrials.gov/data-api/about-api/csv-download\n",
    "\n",
    "# new API fields - for JSON\n",
    "extract_fields = [\n",
    "    'NCTId',\n",
    "    'Condition',\n",
    "    'BriefTitle',\n",
    "    'HasResults',\n",
    "    \"Intervention\",\n",
    "    #'PrimaryOutcome',\n",
    "    'OutcomeMeasuresModule',\n",
    "    #'NumPhases',\n",
    "    'Phase',\n",
    "    'OverallStatus',\n",
    "    'StudyType',\n",
    "    'BriefSummary',\n",
    "    #'LastKnownStatus',\n",
    "\n",
    "]\n",
    "#OutcomeMeasuresModule \n",
    "# new API fields\n",
    "params = {\n",
    "    'fields': \",\".join(extract_fields), \n",
    "    'query.term': '''\"Colorectal Cancer\"''',\n",
    "    'query.intr': 'Cetuximab',\n",
    "    #'filter.overallStatus':'',\n",
    "    'pageSize': 1, # maximum number of !!studies!! to return in response\n",
    "    #'aggFilters':'results:with',\n",
    "    'format': 'json', \n",
    "    #'pageToken': None  # first page doesn't need it\n",
    "}    \n",
    "all_studies = []\n",
    "results_studies = []\n",
    "no_results_studies = []\n",
    "next_page_token='a'\n",
    "page_temp = 0\n",
    "while next_page_token and page_temp<2:\n",
    "\n",
    "    #print(f'--- page: {page} ---')\n",
    "\n",
    "    response = requests.get(base, params=params)\n",
    "\n",
    "    if not response.ok:\n",
    "        print('response.text:', response.text)\n",
    "        break\n",
    "\n",
    "    data = response.json()\n",
    "    #print(data.keys())\n",
    "    data_responses = data['studies']\n",
    "    #print(data_responses)\n",
    "\n",
    "    all_studies = all_studies+data_responses\n",
    "    '''\n",
    "    for index, item_main in enumerate(data_responses, 1):\n",
    "        #print(item)\n",
    "        item = item_main['protocolSection']['identificationModule']\n",
    "        #print(item)\n",
    "\n",
    "        print(f'{page:2},{index:4}:', item_main['protocolSection']['statusModule']['overallStatus'], \n",
    "              #item_main['protocolSection']['statusModule']['lastKnownStatus'],\n",
    "              item_main['protocolSection']['designModule']['phases'],\n",
    "              #item_main['protocolSection']['designModule']['numPhases'],\n",
    "              #item_main['resultsSection']['outcomeMeasuresModule']['outcomeMeasures'], \n",
    "              item['nctId'], item['briefTitle'])\n",
    "        '''\n",
    "\n",
    "    try:\n",
    "    # next page\n",
    "    #next_page_token = response.headers.get('x-next-page')  # (probably) for `CSV`\n",
    "        next_page_token = data['nextPageToken']                 # for `JSON`\n",
    "        print(data['nextPageToken'])\n",
    "    #print('x-next-page', next_page_token)    \n",
    "        params['pageToken'] = next_page_token\n",
    "    except KeyError:\n",
    "        next_page_token=''\n",
    "        pass\n",
    "    page_temp+=1\n",
    "\n",
    "all_studies = pd.json_normalize(all_studies)\n",
    "print(all_studies.columns)\n",
    "'''\n",
    "['hasResults','nctId','briefTitle','overallStatus',\n",
    " 'briefSummary','conditions','studyType','interventions']\n",
    "'''\n",
    "\n",
    "all_studies.columns = [i.split('.')[-1] for i in all_studies.columns]\n",
    "\n",
    "if 'outcomeMeasures' not in all_studies.columns:\n",
    "    all_studies['outcomeMeasures']=None\n",
    "    \n",
    "all_studies    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "8f4a5a47-3945-4ca7-b64c-e62d2f626ee6",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(2, 10)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chosen[chosen.res_with_part.str.len()>0].shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "6a5b3dcf-742e-4c19-97d0-b3cbc3891a66",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3      2\n",
       "4      0\n",
       "11    10\n",
       "Name: res_with_part, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chosen.res_with_part.str.len()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "31671006-59d4-484d-9a52-4fae80baa048",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>results</th>\n",
       "      <th>id</th>\n",
       "      <th>title</th>\n",
       "      <th>status</th>\n",
       "      <th>conditions</th>\n",
       "      <th>study_type</th>\n",
       "      <th>phases</th>\n",
       "      <th>interventions</th>\n",
       "      <th>outcomes</th>\n",
       "      <th>res_with_part</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT00703976</td>\n",
       "      <td>Radiation, Cetuximab and Pemetrexed With or Wi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[bevacizumab, cetuximab, pemetrexed]</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': '2-year Progress...</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': '2-year Progress...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>True</td>\n",
       "      <td>NCT01787006</td>\n",
       "      <td>Definitive Radiochemotherapy Plus/Minus Cetuxi...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>[Esophageal Cancer]</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>[PHASE2]</td>\n",
       "      <td>[cetuximab, cisplatin, 5-fu]</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Rate of Partici...</td>\n",
       "      <td>[{'type': 'PRIMARY', 'title': 'Rate of Partici...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    results           id                                              title  \\\n",
       "3      True  NCT00703976  Radiation, Cetuximab and Pemetrexed With or Wi...   \n",
       "11     True  NCT01787006  Definitive Radiochemotherapy Plus/Minus Cetuxi...   \n",
       "\n",
       "       status           conditions      study_type    phases  \\\n",
       "3   COMPLETED             [Cancer]  INTERVENTIONAL  [PHASE2]   \n",
       "11  COMPLETED  [Esophageal Cancer]  INTERVENTIONAL  [PHASE2]   \n",
       "\n",
       "                           interventions  \\\n",
       "3   [bevacizumab, cetuximab, pemetrexed]   \n",
       "11          [cetuximab, cisplatin, 5-fu]   \n",
       "\n",
       "                                             outcomes  \\\n",
       "3   [{'type': 'PRIMARY', 'title': '2-year Progress...   \n",
       "11  [{'type': 'PRIMARY', 'title': 'Rate of Partici...   \n",
       "\n",
       "                                        res_with_part  \n",
       "3   [{'type': 'PRIMARY', 'title': '2-year Progress...  \n",
       "11  [{'type': 'PRIMARY', 'title': 'Rate of Partici...  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chosen[chosen.res_with_part.str.len()>0].head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "10ed90cc-5e0b-473c-b756-7efc1a32062b",
   "metadata": {},
   "outputs": [],
   "source": [
    "from trialmind.llm_utils.openai_async import batch_call_openai"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "37f1ccfb-f682-457e-bf61-1bed5aad563c",
   "metadata": {
    "tags": []
   },
   "source": [
    "### outcome results\n",
    "Взяли все результаты, отдельно сохранили испытания с результатами, и з них отбираем рез-ты только с unit==participants\n",
    "\n",
    "filter by interventional study type?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "d49df219-e6db-4e19-bad8-064aec8aba27",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\AppData\\Local\\Temp\\ipykernel_3488\\967050974.py:4: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x \\\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2\n",
      "10\n",
      "**Outcome Measure 1: 2-Year Progression-Free Survival (PFS)**\n",
      "\n",
      "- **Efficiency Statistics:** \n",
      "  - Group OG000: 79% (90% CI: 69%-92%)\n",
      "  - Group OG001: 75% (90% CI: 64%-88%)\n",
      "  \n",
      "**Outcome Measure 2: 2-Year Overall Survival (OS)**\n",
      "\n",
      "- **Efficiency Statistics:** \n",
      "  - All Participants (Overall Study): 88% (95% CI: 81%-96%)\n",
      "  - Group OG001: 91% (95% CI: 82%-100%)\n",
      "  - Group OG002: 87% (95% CI: 77%-98%)\n",
      "-----\n",
      "Here are the efficiency statistics for each outcome measure:\n",
      "\n",
      "1. **Rate of Participants Alive at 2 Years**  \n",
      "   - Group OG000: 71%, CI: 55–87%\n",
      "   - Group OG001: 53%, CI: 36–71%\n",
      "\n",
      "2. **Rate of Participants Alive at 1 Year**  \n",
      "   - Group OG000: 74%, CI: 59–90%\n",
      "   - Group OG001: 70%, CI: 54–86%\n",
      "\n",
      "3. **Rate of Participants Alive Without Progression at 1 Year**  \n",
      "   - Group OG000: 64%, CI: 47–82%\n",
      "   - Group OG001: 58%, CI: 40–75%\n",
      "\n",
      "4. **Rate of Participants Alive Without Progression at 2 Years**  \n",
      "   - Group OG000: 56%, CI: 37–75%\n",
      "   - Group OG001: 44%, CI: 26–62%\n",
      "\n",
      "5. **Number of Participants With ≥Grade 3 Toxicity**  \n",
      "   - Group OG000: 26/32\n",
      "   - Group OG001: 27/36\n",
      "\n",
      "6. **Rate of Participants Alive Without Distant Metastases at 1 Year**  \n",
      "   - Group OG000: 79%, CI: 64–94%\n",
      "   - Group OG001: 70%, CI: 53–86%\n",
      "\n",
      "7. **Rate of Participants Alive Without Distant Metastases at 2 Years**  \n",
      "   - Group OG000: 74%, CI: 57–91%\n",
      "   - Group OG001: 54%, CI: 36–73%\n",
      "\n",
      "8. **Number of Responders (Objective Response)**  \n",
      "   - Group OG000: 26/32\n",
      "   - Group OG001: 25/36\n",
      "\n",
      "9. **Rate of Participants Alive Without Loco-regional Failure at 1 Year**  \n",
      "   - Group OG000: 89%, CI: 77–100%\n",
      "   - Group OG001: 81%, CI: 67–95%\n",
      "\n",
      "10. **Rate of Participants Alive Without Loco-regional Failure at 2 Years**  \n",
      "    - Group OG000: 84%, CI: 70–99%\n",
      "    - Group OG001: 72%, CI: 55–89%\n",
      "-----\n"
     ]
    }
   ],
   "source": [
    "at_once = False\n",
    "\n",
    "chosen = all_studies[all_studies.results==True]\n",
    "chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x \\\n",
    "                                                          if(obj.get('unitOfMeasure','').lower() in ['percentage of participants','participants'])])\n",
    "\n",
    "to_work = chosen[chosen.res_with_part.str.len()>0]\n",
    "if to_work.shape[0]:\n",
    "    messages = []\n",
    "    for i in to_work.res_with_part.values[:2]:\n",
    "        n_outcomes = len(i)\n",
    "        print(n_outcomes)\n",
    "        messages.append([{'role':'system', 'content':f'You are a helpful medical assistant. Answer with a concise description of the efficiency statistics for EACH of {n_outcomes} provided outcome measures /no_think'},\n",
    "                {'role':'user', 'content':f\"{i}\"}])\n",
    "    if at_once:\n",
    "        results = batch_call_openai(messages, os.getenv('MODEL_NAME'), int(os.getenv('TEMPERATURE')), thinking=False)\n",
    "    else:\n",
    "        results = []\n",
    "        for i in messages:\n",
    "            answer = extract.use_llm(os.getenv('MODEL_NAME'),i)\n",
    "            results.append(answer)\n",
    "    for i in results:\n",
    "        print(i)\n",
    "        print('-----')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "e0034192-ab00-4acf-ab8b-09830756d13c",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\AppData\\Local\\Temp\\ipykernel_17840\\480369459.py:4: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x if(obj.get('unitOfMeasure','') == 'Participants')])\n"
     ]
    },
    {
     "ename": "ValueError",
     "evalue": "The truth value of a DataFrame is ambiguous. Use a.empty, a.bool(), a.item(), a.any() or a.all().",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mValueError\u001b[39m                                Traceback (most recent call last)",
      "\u001b[32m~\\AppData\\Local\\Temp\\ipykernel_17840\\480369459.py\u001b[39m in \u001b[36m?\u001b[39m\u001b[34m()\u001b[39m\n\u001b[32m     16\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m results\n\u001b[32m     17\u001b[39m     \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m     18\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m     19\u001b[39m \n\u001b[32m---> \u001b[39m\u001b[32m20\u001b[39m res = results_ct(all_studies)\n\u001b[32m     21\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;28;01min\u001b[39;00m res:\n\u001b[32m     22\u001b[39m     print(i)\n\u001b[32m     23\u001b[39m     print(\u001b[33m'-----'\u001b[39m)\n",
      "\u001b[32m~\\AppData\\Local\\Temp\\ipykernel_17840\\480369459.py\u001b[39m in \u001b[36m?\u001b[39m\u001b[34m(all_studies)\u001b[39m\n\u001b[32m      3\u001b[39m     chosen = all_studies[all_studies.results==\u001b[38;5;28;01mTrue\u001b[39;00m]\n\u001b[32m      4\u001b[39m     chosen[\u001b[33m'res_with_part'\u001b[39m] = chosen.outcomes.apply(\u001b[38;5;28;01mlambda\u001b[39;00m x: [obj \u001b[38;5;28;01mfor\u001b[39;00m obj \u001b[38;5;28;01min\u001b[39;00m x \u001b[38;5;28;01mif\u001b[39;00m(obj.get(\u001b[33m'unitOfMeasure'\u001b[39m,\u001b[33m''\u001b[39m) == \u001b[33m'Participants'\u001b[39m)])\n\u001b[32m      5\u001b[39m \n\u001b[32m      6\u001b[39m     to_work = chosen[chosen.res_with_part.str.len()>\u001b[32m0\u001b[39m].iloc[:\u001b[32m2\u001b[39m]\n\u001b[32m----> \u001b[39m\u001b[32m7\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m to_work:\n\u001b[32m      8\u001b[39m         outcome_participants = [obj for item_main in chosen.outcomes.values for obj in item_main \n\u001b[32m      9\u001b[39m                             \u001b[38;5;28;01mif\u001b[39;00m(obj.get(\u001b[33m'unitOfMeasure'\u001b[39m,\u001b[33m''\u001b[39m) == \u001b[33m'Participants'\u001b[39m)]\n\u001b[32m     10\u001b[39m         messages = []\n",
      "\u001b[32m~\\anaconda3\\envs\\llms\\Lib\\site-packages\\pandas\\core\\generic.py\u001b[39m in \u001b[36m?\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m   1578\u001b[39m     @final\n\u001b[32m   1579\u001b[39m     \u001b[38;5;28;01mdef\u001b[39;00m __nonzero__(self) -> NoReturn:\n\u001b[32m-> \u001b[39m\u001b[32m1580\u001b[39m         raise ValueError(\n\u001b[32m   1581\u001b[39m             f\"The truth value of a {type(self).__name__} is ambiguous. \"\n\u001b[32m   1582\u001b[39m             \u001b[33m\"Use a.empty, a.bool(), a.item(), a.any() or a.all().\"\u001b[39m\n\u001b[32m   1583\u001b[39m         )\n",
      "\u001b[31mValueError\u001b[39m: The truth value of a DataFrame is ambiguous. Use a.empty, a.bool(), a.item(), a.any() or a.all()."
     ]
    }
   ],
   "source": [
    "temperature=0\n",
    "def results_ct(all_studies):\n",
    "    chosen = all_studies[all_studies.results==True]\n",
    "    chosen['res_with_part'] = chosen.outcomes.apply(lambda x: [obj for obj in x if(obj.get('unitOfMeasure','') == 'Participants')])\n",
    "    \n",
    "    to_work = chosen[chosen.res_with_part.str.len()>0].iloc[:2]\n",
    "    if to_work:\n",
    "        outcome_participants = [obj for item_main in chosen.outcomes.values for obj in item_main \n",
    "                            if(obj.get('unitOfMeasure','') == 'Participants')] \n",
    "        messages = []\n",
    "        for i in to_work.res_with_part.values:\n",
    "            messages.append([{'role':'system', 'content':'You are a helpful medical assistant. Extract information about the efficiency statistics from each outcome measure. Give: 1) a concise description of results with percentages and 2) a short description of study objectives /no_think'},\n",
    "                    {'role':'user', 'content':f\"{i}\"}])\n",
    "\n",
    "        results = batch_call_openai(messages, os.getenv('MODEL_NAME'), int(os.getenv('TEMPERATURE')), thinking=False)\n",
    "        return results\n",
    "    else:\n",
    "        return None\n",
    "\n",
    "res = results_ct(all_studies)\n",
    "for i in res:\n",
    "    print(i)\n",
    "    print('-----')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "db6360d3-76fa-4607-8764-0a705af4464c",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'llm_reasoning' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[19]\u001b[39m\u001b[32m, line 7\u001b[39m\n\u001b[32m      1\u001b[39m prompt2 = ChatPromptTemplate.from_messages([\n\u001b[32m      2\u001b[39m     (\u001b[33m\"\u001b[39m\u001b[33msystem\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mYou are a helpful medical assistant. Extract information about the efficiency statistics from each outcome measure. Give a concise description with percentages /no_think\u001b[39m\u001b[33m\"\u001b[39m),\n\u001b[32m      3\u001b[39m     (\u001b[33m\"\u001b[39m\u001b[33mhuman\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[38;5;132;01m{text}\u001b[39;00m\u001b[33m\"\u001b[39m),\n\u001b[32m      4\u001b[39m     \u001b[38;5;66;03m# (\"ai\", \"Good.\")\u001b[39;00m\n\u001b[32m      5\u001b[39m ])\n\u001b[32m----> \u001b[39m\u001b[32m7\u001b[39m chain2 = prompt2 | \u001b[43mllm_reasoning\u001b[49m\n\u001b[32m      8\u001b[39m response_res = \u001b[38;5;28;01mawait\u001b[39;00m chain2.ainvoke({\u001b[33m\"\u001b[39m\u001b[33mtext\u001b[39m\u001b[33m\"\u001b[39m: outcome_participants[\u001b[32m0\u001b[39m]})\n\u001b[32m      9\u001b[39m \u001b[38;5;28mprint\u001b[39m(response_res.content)\n",
      "\u001b[31mNameError\u001b[39m: name 'llm_reasoning' is not defined"
     ]
    }
   ],
   "source": [
    "prompt2 = ChatPromptTemplate.from_messages([\n",
    "    (\"system\", \"You are a helpful medical assistant. Extract information about the efficiency statistics from each outcome measure. Give a concise description with percentages /no_think\"),\n",
    "    (\"human\", \"{text}\"),\n",
    "    # (\"ai\", \"Good.\")\n",
    "])\n",
    "\n",
    "chain2 = prompt2 | llm_reasoning\n",
    "response_res = await chain2.ainvoke({\"text\": outcome_participants[0]})\n",
    "print(response_res.content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "84f5d879-2920-4ec3-bac4-5ae64fb55099",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "e706ee64-c65f-40a9-8606-8e71c97fa5d6",
   "metadata": {
    "jp-MarkdownHeadingCollapsed": true,
    "tags": []
   },
   "source": [
    "### results in a given format?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8f1d0545-8778-43fb-9af8-da1730e79453",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "class Info(BaseModel):\n",
    "    diagnose: str = Field(..., description=\"База клинических испытаний\")\n",
    "    treatments: str = Field(..., description=\"Высшие позиции рейтинга таргетных препаратов\")\n",
    "\n",
    "parser = PydanticOutputParser(pydantic_object=Info)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1d5b0edc-bb8f-4fcd-b443-36745ad7eaf7",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "prompt = ChatPromptTemplate.from_messages([\n",
    "    (\n",
    "        \"system\", \n",
    "        dedent(\n",
    "            \"\"\"\n",
    "            You are a helpful assistant. \n",
    "            Your goal is to extract related information from the text provided by the user.\n",
    "            Return the information in the following JSON-format.\n",
    "            {fmt}\n",
    "            \"\"\"\n",
    "        )\n",
    "    ),\n",
    "    (\n",
    "        \"human\", \n",
    "        dedent(\n",
    "            \"\"\"\n",
    "            Text: {text}\"\n",
    "            \"\"\"\n",
    "        )\n",
    "    ),\n",
    "])\n",
    "chain = (\n",
    "    prompt \n",
    "    | llm_reasoning \n",
    "    | parser\n",
    ")\n",
    "\n",
    "\n",
    "response = await chain.ainvoke({\"text\": text, \"fmt\": parser.get_format_instructions()})\n",
    "print(response)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d963b7db-0c01-4b5f-af74-d7d566ae8a54",
   "metadata": {
    "tags": []
   },
   "source": [
    "### papers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "f1e430e6-c0a6-4a2f-9e92-2b0ca80bdd6e",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "fin_condition = 'Colorectal cancer'\n",
    "treatements_eng =  ['Crizotinib','Lorlatinib',]\n",
    "pubmed_api_key= '6892c4129cef143ff92d11533848d2e0d908'#os.getenv(\"PUBMED_API_KEY\", '')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ceab5c26-765a-420c-82a6-8bfbacdb36f6",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(['40526090', '41213063', '41268440'],\n",
       " 'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(Colorectal cancer)+AND+(Crizotinib)&retmax=3&retmode=json&api_key=6892c4129cef143ff92d11533848d2e0d908',\n",
       " '67')"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "search_api = PubmedAPIWrapper()\n",
    "# page_size is the max number of records to return!!!! not pages!\n",
    "tmp_inputs = {\n",
    "        \"page_size\": 3,\n",
    "        \"keyword_map\": {'conditions':[fin_condition], \n",
    "                        'treatments':[treatements_eng[0]]\n",
    "                       },\n",
    "        \"keywords\": {\n",
    "            \"OPERATOR\": 'AND'\n",
    "        }\n",
    "}\n",
    "\n",
    "time.sleep(.5)\n",
    "response = search_api.build_search_query_and_get_pmid(tmp_inputs, \n",
    "                                                      api_key=pubmed_api_key)\n",
    "response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "a54a4f2c-d723-4a4a-a1b1-77eb50eeaea8",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PMID</th>\n",
       "      <th>Journal</th>\n",
       "      <th>Year</th>\n",
       "      <th>Month</th>\n",
       "      <th>Day</th>\n",
       "      <th>Title</th>\n",
       "      <th>Publication Type</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>40526090</td>\n",
       "      <td>Oncotarget</td>\n",
       "      <td>2025</td>\n",
       "      <td>Jun</td>\n",
       "      <td>17</td>\n",
       "      <td>Case Report WIN-MTB-2023001 WIN International ...</td>\n",
       "      <td>Journal Article, Case Reports</td>\n",
       "      <td>Alberto Hernando-Calvo, Razelle Kurzrock, Nadi...</td>\n",
       "      <td>Heavily pretreated metastatic colorectal cance...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>41213063</td>\n",
       "      <td>Journal of environmental pathology, toxicology...</td>\n",
       "      <td>2025</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Radiotherapy-Related Autophagy Genes Predict P...</td>\n",
       "      <td>Journal Article</td>\n",
       "      <td>Mao Mao, Yichao Zhuang, Yan Chen</td>\n",
       "      <td>Numerous genes have been associated with color...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>41268440</td>\n",
       "      <td>Frontiers in pharmacology</td>\n",
       "      <td>2025</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Case Report: HGF and NF1 mutations as putative...</td>\n",
       "      <td>Case Reports, Journal Article</td>\n",
       "      <td>Zhitao Chen, Shan Luo, Yangjun Gu, Qiyong Li</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a highly agg...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       PMID                                            Journal  Year Month  \\\n",
       "0  40526090                                         Oncotarget  2025   Jun   \n",
       "1  41213063  Journal of environmental pathology, toxicology...  2025         \n",
       "2  41268440                          Frontiers in pharmacology  2025         \n",
       "\n",
       "  Day                                              Title  \\\n",
       "0  17  Case Report WIN-MTB-2023001 WIN International ...   \n",
       "1      Radiotherapy-Related Autophagy Genes Predict P...   \n",
       "2      Case Report: HGF and NF1 mutations as putative...   \n",
       "\n",
       "                Publication Type  \\\n",
       "0  Journal Article, Case Reports   \n",
       "1                Journal Article   \n",
       "2  Case Reports, Journal Article   \n",
       "\n",
       "                                             Authors  \\\n",
       "0  Alberto Hernando-Calvo, Razelle Kurzrock, Nadi...   \n",
       "1                   Mao Mao, Yichao Zhuang, Yan Chen   \n",
       "2       Zhitao Chen, Shan Luo, Yangjun Gu, Qiyong Li   \n",
       "\n",
       "                                            Abstract  \n",
       "0  Heavily pretreated metastatic colorectal cance...  \n",
       "1  Numerous genes have been associated with color...  \n",
       "2  Hepatocellular carcinoma (HCC) is a highly agg...  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_papers = pmid2papers(pmid_list=['40526090', '41213063', '41268440'],#response[0], \n",
    "                        api_key=pubmed_api_key)\n",
    "df_papers[0].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "dd4f5664-3983-4bbb-af9f-7f460b87e5e3",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('Colorectal cancer', ['Crizotinib', 'Lorlatinib'])"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fin_condition, treatements_eng"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f15bedd0-7b97-4696-ac71-2b9ddc4ef0d6",
   "metadata": {},
   "source": [
    "### extract results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "365da54d-32aa-445c-b27b-0b6b2ae80cf6",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "fin_condition = 'Colorectal cancer'\n",
    "treatements_eng =  ['Crizotinib','Lorlatinib',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "033c3e2a-28c7-4d05-b135-1078f19e8e3d",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'MDE5YmM2MjctOWU5ZS03OWE0LWE0OGYtY2FhMTU4MzYxZDgzOjg2MjAwMDgzLThkNzMtNGU0ZS1hNzIxLTM3YWY5ZWY4ZmZlNg=='"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "os.getenv(\"GIGACHAT_AUTH\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2f9825e3-9cba-4bc3-9278-f9d294302f69",
   "metadata": {},
   "source": [
    "### get sber api"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "66ffb1de-672b-4c10-acfc-bcade11f8c7d",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user\\anaconda3\\envs\\llms\\Lib\\site-packages\\urllib3\\connectionpool.py:1097: InsecureRequestWarning: Unverified HTTPS request is being made to host 'ngw.devices.sberbank.ru'. Adding certificate verification is strongly advised. See: https://urllib3.readthedocs.io/en/latest/advanced-usage.html#tls-warnings\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'eyJjdHkiOiJqd3QiLCJlbmMiOiJBMjU2Q0JDLUhTNTEyIiwiYWxnIjoiUlNBLU9BRVAtMjU2In0.AUismEA_iypp1Wa3hGSGS_CGMe9ZNJYFoaPG43Jz94F53ubk4aa_UdZU5JJGTB7M2A-gbyGdaeQVLK6KEEjVdiAITdOa4Cazz9khlamOsPv9kZKS0XQlWAoNJ3WejWx9iL5za4Y4FKfROi7MaNeCZQu8pO-DslBYqBkoJmpg_tSuelDE9ldFzwFzAM_Cc2PsyJTBfkWxhi3qdqhJ6kE77mp0mvVULOxvNMOSlI9b0mmIm3q4kJemumusdKKo8FTZCn2Ub6VbvAnebVUuYywE4OctKMbOe0MjoYDh1VO8_jcW6dgANcsPNfwHKRnD_UqVs85v6_bnOhSIimi45nqH5w.ziBWyLF-sztnPom5QV8fPg.a7t8GaPBh9wuxMLMO-qkwuTzlqlQEgeDQXLEzPoOggxuVb-5ezFfAMLvV1UAgAyFhJEGF-RuEycOy2zNRAvTGVyh9i6xVwYu88y-ZkS-1wo7vPAsyBhZJuGH6rqJCbnAeqT9gF0ZTjAg2w35WAEpPkKpMaFhILyIh85Tnc8q1i61Fo-qwVke66uMq5vwNiIREH5hBi1YmliWgPg5BhIVfyGaYNwa7Lsd8ApxBLNTxV1aW3XqxoqOcOjkPUmltypJ0_kr27kqCjmhw-PVC-BV6UVB5liMbdbg-2W9yR6pZc1lZ6_Wl9b9YnpJBm2jxY1oe8Kc0-buTLNC6-V52oftlk7-hKm-nRUI2L-3A3iDIj6dqsNRE2q_shOvvG4eh9ArULHISG_w4wjVed2O_8nivDWjinE47LfgstH0_Jl-c_WXbsV6h82f3fOBauvgHZeBo4PYikMFZkSdMfhezjYF2cRdY__r5eUB_rvFVK7wZ5BwcZdng4JibdXJvCA-Sy4LWbParXM6puf_BlettkEUrYIWsd2B5uED1-4vQ2g9l8MU8BpJ9MKtP9z9o7odhSpRiPG0np0XOqPsetEVTHpgCC-6MZ7eYwnrowK5ZjH-rgLv1hF3Qmgb6VujN0eXonAXGukMxXC2_5N1PnZ-MtkfSTylxePXPHYs8fK29pckzxSuRdFv8q0C3RUewEv1XvZUS5ojpK-P0PdoTLLsTa2Q51Hcrd3kR7hQMJhlLPHwZj4.DEIFD6pZTBDgVFAMtZ2R-evmio6kig_ynjzUP1btKOw'"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "720ecef2-268b-4b8e-8241-96b44d26d0bf",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "4e632a26-387b-4c21-b67c-5408ce327484",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "02abfa1e-39b7-4f19-b669-16f0cc72cad5",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "call_openai https://gigachat.devices.sberbank.ru/api/v1\n",
      "api_call_single https://gigachat.devices.sberbank.ru/api/v1/\n",
      "```json\n",
      "{\n",
      "  \"ELIGIBILITY_ANALYSIS\": [\n",
      "    \"Patients must have colorectal cancer — Studies focusing on other types of cancers would not contribute relevant data.\",\n",
      "    \"Studies involving patients receiving crizotinib as an intervention — Exclusion of studies using different treatments ensures consistency in the analysis.\",\n",
      "    \"Comparative studies where crizotinib is compared against another treatment or placebo — Inclusion of comparative studies allows for direct comparison of outcomes between crizotinib and alternative therapies.\",\n",
      "    \"Studies reporting outcomes related to efficacy, safety, or survival — The focus is on evaluating effectiveness and adverse effects of crizotinib.\",\n",
      "    \"Published studies in peer-reviewed journals — Ensures quality and reliability of the evidence.\"\n",
      "  ],\n",
      "  \"TITLE_CRITERIA\": [\n",
      "    \"Does the title mention 'colorectal cancer'?\",\n",
      "    \"Does the title include 'crizotinib'?\"\n",
      "  ],\n",
      "  \"CONTENT_CRITERIA\": [\n",
      "    \"Is there a clear description of patient population with colorectal cancer?\",\n",
      "    \"Are the results reported in terms of efficacy, toxicity, or survival rates associated with crizotinib use?\"\n",
      "  ]\n",
      "}\n",
      "```  \n",
      "\n",
      "This structured approach follows the PRISMA guidelines and ensures that only relevant studies are selected for inclusion in the meta-analysis.\n"
     ]
    }
   ],
   "source": [
    "# test the apis\n",
    "\n",
    "api = ScreeningCriteriaGeneration()\n",
    "ecs = api.run(\n",
    "    population = f\"Patients with {fin_condition} undergoing treatment with {treatements_eng[0]}\",\n",
    "    intervention = f\"{treatements_eng[0]}\",\n",
    "    comparator = \"\",\n",
    "    outcome = \"\",\n",
    "    llm = os.getenv(\"MODEL_NAME\"),\n",
    "    num_title_criteria=2,\n",
    "    num_abstract_criteria=2,\n",
    "    thinking=False,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "376aa03a-6c9b-4901-9f9f-d8904db556d7",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'title_criteria': [\"Does the title mention 'colorectal cancer'?\",\n",
       "  \"Does the title include 'crizotinib'?\"],\n",
       " 'content_criteria': ['Is there a clear description of patient population with colorectal cancer?',\n",
       "  'Are the results reported in terms of efficacy, toxicity, or survival rates associated with crizotinib use?'],\n",
       " 'eligibility_analysis': ['Patients must have colorectal cancer — Studies focusing on other types of cancers would not contribute relevant data.',\n",
       "  'Studies involving patients receiving crizotinib as an intervention — Exclusion of studies using different treatments ensures consistency in the analysis.',\n",
       "  'Comparative studies where crizotinib is compared against another treatment or placebo — Inclusion of comparative studies allows for direct comparison of outcomes between crizotinib and alternative therapies.',\n",
       "  'Studies reporting outcomes related to efficacy, safety, or survival — The focus is on evaluating effectiveness and adverse effects of crizotinib.',\n",
       "  'Published studies in peer-reviewed journals — Ensures quality and reliability of the evidence.']}"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ecs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f2858acb-a1e3-4d89-b8af-f1b7ce0cf1d4",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "\n",
    "papers = df_papers[0].iloc[:3][\"Title\"] + \": \" + df_papers[0].iloc[:3][\"Abstract\"].fillna(\"\") # important to fillna\n",
    "papers = papers.tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "e604d682-87c0-4bcb-97c0-0c4109f1bdd3",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'ecs' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[16]\u001b[39m\u001b[32m, line 12\u001b[39m\n\u001b[32m      1\u001b[39m \u001b[33;03m'''\u001b[39;00m\n\u001b[32m      2\u001b[39m \u001b[33;03mtitle_criteria = [\"Does the title mention 'colorectal cancer'?\",\u001b[39;00m\n\u001b[32m      3\u001b[39m \u001b[33;03m\"Does the title mention 'crizotinib'?\",\u001b[39;00m\n\u001b[32m   (...)\u001b[39m\u001b[32m     10\u001b[39m \u001b[33;03m  ]\u001b[39;00m\n\u001b[32m     11\u001b[39m \u001b[33;03m'''\u001b[39;00m\n\u001b[32m---> \u001b[39m\u001b[32m12\u001b[39m title_criteria = \u001b[43mecs\u001b[49m[\u001b[33m'\u001b[39m\u001b[33mtitle_criteria\u001b[39m\u001b[33m'\u001b[39m]\n\u001b[32m     13\u001b[39m content_criteria = ecs[\u001b[33m'\u001b[39m\u001b[33mcontent_criteria\u001b[39m\u001b[33m'\u001b[39m]\n\u001b[32m     14\u001b[39m title_criteria+content_criteria\n",
      "\u001b[31mNameError\u001b[39m: name 'ecs' is not defined"
     ]
    }
   ],
   "source": [
    "'''\n",
    "title_criteria = [\"Does the title mention 'colorectal cancer'?\",\n",
    "\"Does the title mention 'crizotinib'?\",\n",
    "\"Is there any indication in the title that the study compares crizotinib to another treatment?\"\n",
    "]\n",
    "\n",
    "content_criteria = [\"Are the methods section and results clearly described in the paper?\",\n",
    "\"Does the study specify the type of colorectal cancer (e.g., adenocarcinoma)?\",\n",
    "\"Were the outcomes measured over a sufficient duration to assess long-term effects?\"\n",
    "  ]\n",
    "'''\n",
    "title_criteria = ecs['title_criteria']\n",
    "content_criteria = ecs['content_criteria']\n",
    "title_criteria+content_criteria"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "84ce6a39-e6df-43d9-962a-d091b96c154f",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "title_criteria = [\"Does the title mention 'colorectal cancer'?\",\n",
    "\"Does the title mention 'crizotinib'?\",\n",
    "\"Is there any indication in the title that the study compares crizotinib to another treatment?\"\n",
    "]\n",
    "\n",
    "content_criteria = [\"Are the methods section and results clearly described in the paper?\",\n",
    "\"Does the study specify the type of colorectal cancer (e.g., adenocarcinoma)?\",\n",
    "\"Were the outcomes measured over a sufficient duration to assess long-term effects?\"\n",
    "  ]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f0cda940-cb13-4465-8adf-ae6322492ae4",
   "metadata": {},
   "source": [
    "### lit screen"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "01b591d1-9455-484c-84d8-5257ddb17838",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "from trialmind.llm import _batch_inputs_to_messages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1952514e-39be-48fd-a185-1840dfaf2ddc",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n# CONTEXT #\\nYou are a clinical specialist tasked with assessing research papers for inclusion in a meta-analysis based on specific eligibility criteria.\\n\\n# OBJECTIVE #\\nEvaluate each criterion of a given paper to determine its eligibility for inclusion in the meta-analysis. Provide a list of decisions (\"YES\", \"NO\", or \"UNCERTAIN\") for each eligibility criterion. You must deliver exactly {num_criteria} responses.\\n\\n# IMPORTANT NOTE #\\nIf the information within the provided paper content is insufficient to conclusively evaluate a criterion, you must opt for \"UNCERTAIN\" as your response. Avoid making assumptions or extrapolating beyond the provided data, as accurate and reliable responses are crucial, and fabricating information (hallucinations) could lead to serious errors in the meta-analysis.\\n\\n# PICO FRAMEWORK #\\n- P (Patient, Problem or Population): {P}\\n- I (Intervention): {I}\\n- C (Comparison): {C}\\n- O (Outcome): {O}\\n\\n# PAPER DETAILS #\\n- Provided Paper: {paper_content}\\n\\n# EVALUATION CRITERIA #\\n- Number of Criteria: {num_criteria}\\n- Criteria for Inclusion: {criteria_text}\\n\\n# RESPONSE FORMAT #\\nReturn the information in a JSON object containing a list of decisions for each of the {num_criteria} eligibility criteria. Each decision should directly correspond to one of the criteria and be listed in the order they are presented. Ensure to use \"UNCERTAIN\" wherever the paper does not explicitly support a \"YES\" or \"NO\" decision.\\n\\nFor example:\\n```json\\n{{\\n    \"evaluations\": [\"YES\", \"NO\", \"UNCERTAIN\", \"YES\", \"YES\", ...],\\n    \"rationale\": [\"The title includes...\",\"...\",\"...\",\"...\",\"...\",...]\\n}}\\n```\\n\\nMANDATORY: Every single response then continues with valid JSON output complying to the included JSON schema, and will be validated, allowing no deviation.\\n'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from trialmind.prompts.screening import LITERATURE_SCREENING_FC\n",
    "population = f\"Patients with {fin_condition} undergoing treatment with {treatements_eng[0]}\",\n",
    "intervention = f\"{treatements_eng[0]}\",\n",
    "comparator = \"\",\n",
    "outcome = \"\",\n",
    "criteria = title_criteria + content_criteria\n",
    "criteria_text = [f\"{idx+1}. {c}\" for idx, c in enumerate(criteria)]\n",
    "n_criteria = len(criteria_text)\n",
    "    \n",
    "batch_inputs = []\n",
    "for paper in papers[:1]:\n",
    "    batch_inputs.append({\n",
    "        \"P\": population,\n",
    "        \"I\": intervention,\n",
    "        \"C\": comparator,\n",
    "        \"O\": outcome,\n",
    "        \"paper_content\": paper,\n",
    "        \"criteria_text\": criteria_text,\n",
    "        \"num_criteria\": n_criteria\n",
    "    })\n",
    "            \n",
    "LITERATURE_SCREENING_FC"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "ea150416-221c-4862-b25e-4d59707e2088",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'type': 'function',\n",
       "  'function': {'name': 'PaperEvaluation',\n",
       "   'description': '',\n",
       "   'parameters': {'properties': {'evaluations': {'description': 'Evaluations for 4 criteria, must be of length 4',\n",
       "      'items': {'enum': ['YES', 'NO', 'UNCERTAIN'], 'type': 'string'},\n",
       "      'maxItems': 4,\n",
       "      'minItems': 4,\n",
       "      'type': 'array'},\n",
       "     'rationale': {'description': 'A rationale for each criteria evaluation',\n",
       "      'items': {'type': 'string'},\n",
       "      'maxItems': 4,\n",
       "      'minItems': 4,\n",
       "      'type': 'array'}},\n",
       "    'required': ['evaluations', 'rationale'],\n",
       "    'type': 'object'}}}]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "c1677a10-4eb7-4811-89db-e49e4f46aa4a",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ChatCompletionMessage(content='```json\\n{\\n  \"evaluations\": [\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\",\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\"\\n  ],\\n  \"rationale\": [\\n    \"The title mentions \\'metastatic colorectal cancer\\'\",\\n    \"The title mentions \\'Crizotinib\\'\",\\n    \"There is no comparison mentioned in the title\",\\n    \"Methods and results sections are briefly described but not detailed enough to confirm clarity\",\\n    \"The text indicates adenocarcinoma as the type of colorectal cancer\",\\n    \"No explicit statement about outcome duration is made\"\\n  ]\\n}\\n```  \\n\\n### Explanation of Decisions:\\n1. **Does the title mention \\'colorectal cancer\\'?**  \\n   *YES* — The title states “metastatic colorectal cancer.”\\n   \\n2. **Does the title mention \\'crizotinib\\'?**  \\n   *YES* — The term “Crizotinib” appears in the title.\\n\\n3. **Is there any indication in the title that the study compares crizotinib to another treatment?**  \\n   *UNCERTAIN* — There’s no direct comparison indicated in the title.\\n\\n4. **Are the methods section and results clearly described in the paper?**  \\n   *YES* — Methods and results are mentioned, though details are sparse.\\n\\n5. **Does the study specify the type of colorectal cancer (e.g., adenocarcinoma)?**  \\n   *YES* — The text specifies it as adenocarcinoma.\\n\\n6. **Were the outcomes measured over a sufficient duration to assess long-term effects?**  \\n   *UNCERTAIN* — No clear evidence of long-term follow-up is stated.', refusal=None, role='assistant', annotations=None, audio=None, function_call=None, tool_calls=None)"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "messages = _batch_inputs_to_messages(prompt_template=LITERATURE_SCREENING_FC, batch_inputs=batch_inputs)\n",
    "\n",
    "from openai import AsyncOpenAI\n",
    "tools = [{'type': 'function', 'function': {'name': 'PaperEvaluation', 'description': '', 'parameters': {'properties': {'evaluations': {'description': 'Evaluations for 4 criteria, must be of length 4', 'items': {'enum': ['YES', 'NO', 'UNCERTAIN'], 'type': 'string'}, 'maxItems': 4, 'minItems': 4, 'type': 'array'}, 'rationale': {'description': 'A rationale for each criteria evaluation', 'items': {'type': 'string'}, 'maxItems': 4, 'minItems': 4, 'type': 'array'}}, 'required': ['evaluations', 'rationale'], 'type': 'object'}}}]\n",
    "\n",
    "async_openai_client = AsyncOpenAI(\n",
    "        base_url=os.getenv(\"BASE_URL\"),\n",
    "        api_key=os.getenv(\"OPENAI_API_KEY\"),\n",
    "        http_client=httpx.AsyncClient(verify=False)\n",
    "    )\n",
    "response = await async_openai_client.chat.completions.create(\n",
    "    model=os.getenv(\"MODEL_NAME\"),\n",
    "    messages=messages[0],\n",
    "    tools=tools,\n",
    "    temperature=0\n",
    ")\n",
    "response.choices[0].message"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "6ecfac9c-3958-4c86-af6a-c7da0038f0dc",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'```json\\n{\\n  \"evaluations\": [\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\",\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\"\\n  ],\\n  \"rationale\": [\\n    \"The title mentions \\'metastatic colorectal cancer\\'\",\\n    \"The title mentions \\'Crizotinib\\'\",\\n    \"There is no comparison mentioned in the title\",\\n    \"Methods and results sections are briefly described but not detailed enough to confirm clarity\",\\n    \"The text indicates adenocarcinoma as the type of colorectal cancer\",\\n    \"No explicit statement about outcome duration is made\"\\n  ]\\n}\\n```  \\n\\n### Explanation of Decisions:\\n1. **Does the title mention \\'colorectal cancer\\'?**  \\n   *YES* — The title states “metastatic colorectal cancer.”\\n   \\n2. **Does the title mention \\'crizotinib\\'?**  \\n   *YES* — The term “Crizotinib” appears in the title.\\n\\n3. **Is there any indication in the title that the study compares crizotinib to another treatment?**  \\n   *UNCERTAIN* — There’s no direct comparison indicated in the title.\\n\\n4. **Are the methods section and results clearly described in the paper?**  \\n   *YES* — Methods and results are mentioned, though details are sparse.\\n\\n5. **Does the study specify the type of colorectal cancer (e.g., adenocarcinoma)?**  \\n   *YES* — The text specifies it as adenocarcinoma.\\n\\n6. **Were the outcomes measured over a sufficient duration to assess long-term effects?**  \\n   *UNCERTAIN* — No clear evidence of long-term follow-up is stated.'"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response.choices[0].message.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "fa1b377c-97de-4216-95ef-57150b672ea3",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "from trialmind.api import extract_json,parse_json_outputs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "f2c7b653-2bb6-4946-b79d-791ee3f4a1aa",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'evaluations': ['YES', 'YES', 'UNCERTAIN', 'YES', 'YES', 'UNCERTAIN'],\n",
       "  'rationale': [\"The title mentions 'metastatic colorectal cancer'\",\n",
       "   \"The title mentions 'Crizotinib'\",\n",
       "   'There is no comparison mentioned in the title',\n",
       "   'Methods and results sections are briefly described but not detailed enough to confirm clarity',\n",
       "   'The text indicates adenocarcinoma as the type of colorectal cancer',\n",
       "   'No explicit statement about outcome duration is made']}]"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "parse_json_outputs([response.choices[0].message.content])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "6e510df2-8174-4105-bcaa-00767e4560ba",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'name': 'PaperEvaluation', 'description': '', 'parameters': {'properties': {'evaluations': {'description': 'Evaluations for 6 criteria, must be of length 6', 'items': {'enum': ['YES', 'NO', 'UNCERTAIN'], 'type': 'string'}, 'maxItems': 6, 'minItems': 6, 'type': 'array'}, 'rationale': {'description': 'A rationale for each criteria evaluation', 'items': {'type': 'string'}, 'maxItems': 6, 'minItems': 6, 'type': 'array'}}, 'required': ['evaluations', 'rationale'], 'type': 'object'}}\n",
      "\n",
      "api_function_call_single https://gigachat.devices.sberbank.ru/api/v1/\n",
      "[{'role': 'user', 'content': '\\n# CONTEXT #\\nYou are a clinical specialist tasked with assessing research papers for inclusion in a meta-analysis based on specific eligibility criteria.\\n\\n# OBJECTIVE #\\nEvaluate each criterion of a given paper to determine its eligibility for inclusion in the meta-analysis. Provide a list of decisions (\"YES\", \"NO\", or \"UNCERTAIN\") for each eligibility criterion. You must deliver exactly 6 responses.\\n\\n# IMPORTANT NOTE #\\nIf the information within the provided paper content is insufficient to conclusively evaluate a criterion, you must opt for \"UNCERTAIN\" as your response. Avoid making assumptions or extrapolating beyond the provided data, as accurate and reliable responses are crucial, and fabricating information (hallucinations) could lead to serious errors in the meta-analysis.\\n\\n# PICO FRAMEWORK #\\n- P (Patient, Problem or Population): Patients with Colorectal cancer undergoing treatment with Crizotinib\\n- I (Intervention): Crizotinib\\n- C (Comparison): \\n- O (Outcome): \\n\\n# PAPER DETAILS #\\n- Provided Paper: Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment.: Heavily pretreated metastatic colorectal cancer (mCRC) poses significant therapeutic challenges. Advances in molecular profiling enables personalized strategies. We present a 62-year-old male with mCRC harboring\\n\\n# EVALUATION CRITERIA #\\n- Number of Criteria: 6\\n- Criteria for Inclusion: [\"1. Does the title mention \\'colorectal cancer\\'?\", \"2. Does the title mention \\'crizotinib\\'?\", \\'3. Is there any indication in the title that the study compares crizotinib to another treatment?\\', \\'4. Are the methods section and results clearly described in the paper?\\', \\'5. Does the study specify the type of colorectal cancer (e.g., adenocarcinoma)?\\', \\'6. Were the outcomes measured over a sufficient duration to assess long-term effects?\\']\\n\\n# RESPONSE FORMAT #\\nReturn the information in a JSON object containing a list of decisions for each of the 6 eligibility criteria. Each decision should directly correspond to one of the criteria and be listed in the order they are presented. Ensure to use \"UNCERTAIN\" wherever the paper does not explicitly support a \"YES\" or \"NO\" decision.\\n\\nFor example:\\n```json\\n{\\n    \"evaluations\": [\"YES\", \"NO\", \"UNCERTAIN\", \"YES\", \"YES\", ...],\\n    \"rationale\": [\"The title includes...\",\"...\",\"...\",\"...\",\"...\",...]\\n}\\n```\\n\\nMANDATORY: Every single response then continues with valid JSON output complying to the included JSON schema, and will be validated, allowing no deviation.\\n'}]\n",
      "\n",
      "TOOLS:  [{'type': 'function', 'function': {'name': 'PaperEvaluation', 'description': '', 'parameters': {'properties': {'evaluations': {'description': 'Evaluations for 6 criteria, must be of length 6', 'items': {'enum': ['YES', 'NO', 'UNCERTAIN'], 'type': 'string'}, 'maxItems': 6, 'minItems': 6, 'type': 'array'}, 'rationale': {'description': 'A rationale for each criteria evaluation', 'items': {'type': 'string'}, 'maxItems': 6, 'minItems': 6, 'type': 'array'}}, 'required': ['evaluations', 'rationale'], 'type': 'object'}}}]\n",
      "\n",
      "response_message ChatCompletionMessage(content='```json\\n{\\n  \"evaluations\": [\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\",\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\"\\n  ],\\n  \"rationale\": [\\n    \"The term \\'colorectal cancer\\' appears in the title.\",\\n    \"The term \\'Crizotinib\\' appears in the title.\",\\n    \"There is no explicit comparison mentioned in the title.\",\\n    \"Methods and results sections are briefly described but not detailed enough to confirm clarity.\",\\n    \"The text mentions adenocarcinoma, which is a specified type of colorectal cancer.\",\\n    \"The paper is a case report and lacks sufficient details about outcome durations.\"\\n  ]\\n}\\n```  \\n\\nExplanation of rationale:\\n1. **Title mentioning \\'colorectal cancer\\':** The title states “metastatic colorectal cancer.”\\n2. **Title mentioning \\'crizotinib\\':** The word \"Crizotinib\" is explicitly stated in the title.\\n3. **Comparative study:** There’s no direct comparison indicated in the title.\\n4. **Methodology description:** While some method descriptions exist, they’re too brief to fully evaluate clarity.\\n5. **Type of colorectal cancer:** The paper specifies it as adenocarcinoma.\\n6. **Duration of outcomes:** The paper is a case report without specifying follow-up periods necessary for evaluating long-term effects.', refusal=None, role='assistant', annotations=None, audio=None, function_call=None, tool_calls=None)\n",
      "!!\n",
      "\n",
      "parsed_results in asynch ['```json\\n{\\n  \"evaluations\": [\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\",\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\"\\n  ],\\n  \"rationale\": [\\n    \"The term \\'colorectal cancer\\' appears in the title.\",\\n    \"The term \\'Crizotinib\\' appears in the title.\",\\n    \"There is no explicit comparison mentioned in the title.\",\\n    \"Methods and results sections are briefly described but not detailed enough to confirm clarity.\",\\n    \"The text mentions adenocarcinoma, which is a specified type of colorectal cancer.\",\\n    \"The paper is a case report and lacks sufficient details about outcome durations.\"\\n  ]\\n}\\n```  \\n\\nExplanation of rationale:\\n1. **Title mentioning \\'colorectal cancer\\':** The title states “metastatic colorectal cancer.”\\n2. **Title mentioning \\'crizotinib\\':** The word \"Crizotinib\" is explicitly stated in the title.\\n3. **Comparative study:** There’s no direct comparison indicated in the title.\\n4. **Methodology description:** While some method descriptions exist, they’re too brief to fully evaluate clarity.\\n5. **Type of colorectal cancer:** The paper specifies it as adenocarcinoma.\\n6. **Duration of outcomes:** The paper is a case report without specifying follow-up periods necessary for evaluating long-term effects.']\n",
      "\n",
      "OUTPUTS:  ['```json\\n{\\n  \"evaluations\": [\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\",\\n    \"YES\",\\n    \"YES\",\\n    \"UNCERTAIN\"\\n  ],\\n  \"rationale\": [\\n    \"The term \\'colorectal cancer\\' appears in the title.\",\\n    \"The term \\'Crizotinib\\' appears in the title.\",\\n    \"There is no explicit comparison mentioned in the title.\",\\n    \"Methods and results sections are briefly described but not detailed enough to confirm clarity.\",\\n    \"The text mentions adenocarcinoma, which is a specified type of colorectal cancer.\",\\n    \"The paper is a case report and lacks sufficient details about outcome durations.\"\\n  ]\\n}\\n```  \\n\\nExplanation of rationale:\\n1. **Title mentioning \\'colorectal cancer\\':** The title states “metastatic colorectal cancer.”\\n2. **Title mentioning \\'crizotinib\\':** The word \"Crizotinib\" is explicitly stated in the title.\\n3. **Comparative study:** There’s no direct comparison indicated in the title.\\n4. **Methodology description:** While some method descriptions exist, they’re too brief to fully evaluate clarity.\\n5. **Type of colorectal cancer:** The paper specifies it as adenocarcinoma.\\n6. **Duration of outcomes:** The paper is a case report without specifying follow-up periods necessary for evaluating long-term effects.']\n",
      "\n",
      "OUTPUTS:  [{'evaluations': ['YES', 'YES', 'UNCERTAIN', 'YES', 'YES', 'UNCERTAIN'], 'rationale': [\"The term 'colorectal cancer' appears in the title.\", \"The term 'Crizotinib' appears in the title.\", 'There is no explicit comparison mentioned in the title.', 'Methods and results sections are briefly described but not detailed enough to confirm clarity.', 'The text mentions adenocarcinoma, which is a specified type of colorectal cancer.', 'The paper is a case report and lacks sufficient details about outcome durations.']}]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[['YES', 'YES', 'UNCERTAIN', 'YES', 'YES', 'UNCERTAIN']]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "api = LiteratureScreening()\n",
    "ec_pred = api.run(\n",
    "    population = f\"Patients with {fin_condition} undergoing treatment with {treatements_eng[0]}\",\n",
    "    intervention = f\"{treatements_eng[0]}\",\n",
    "    comparator = \"\",\n",
    "    outcome = \"\",\n",
    "    llm = os.getenv(\"MODEL_NAME\"),\n",
    "    criteria = title_criteria + content_criteria,\n",
    "    papers = papers[:1], # make for the top-100 for demo\n",
    ")\n",
    "ec_pred"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "64b707f3-1410-4eef-b715-ddbc7528de94",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0e785c6e-737b-4f76-9cdf-d8dce4edf47a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f4442059-f9e6-4373-a9f5-a1c9a9932a7d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "108da99a-9c81-4cde-bc04-89ac3431840a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d71c255e-1f6c-429c-8e14-3c03f724a1bd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "fcc2864f-dc61-4eb8-a720-c4f9040724b5",
   "metadata": {
    "jp-MarkdownHeadingCollapsed": true,
    "tags": []
   },
   "source": [
    "# d"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "c69ff7c4-4e91-4afc-bdae-ec1fbf094012",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_xml/41268440/unicode?api_key=6892c4129cef143ff92d11533848d2e0d908\n",
      "https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_xml/41213063/unicode?api_key=6892c4129cef143ff92d11533848d2e0d908\n",
      "https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_xml/40526090/unicode?api_key=6892c4129cef143ff92d11533848d2e0d908\n",
      "https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_xml/40211189/unicode?api_key=6892c4129cef143ff92d11533848d2e0d908\n",
      "https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_xml/40369167/unicode?api_key=6892c4129cef143ff92d11533848d2e0d908\n"
     ]
    }
   ],
   "source": [
    "pmid_list = df_papers[0].PMID.values.tolist()\n",
    "#['41213063',#'26451310',]\n",
    "\n",
    "res = pmid2biocxml(pmid_list, api_key=pubmed_api_key)\n",
    "#print(res)\n",
    "res = [parse_bioc_xml(r) for r in res]\n",
    "# transform the parsed xml into paper content\n",
    "papers = []\n",
    "for parsed in res:\n",
    "    paper_content = []\n",
    "    for parsed_ in parsed[\"passage\"]:\n",
    "        paper_content.append(parsed_['content'])\n",
    "    paper_content = \"\\n\".join(paper_content)\n",
    "    papers.append(paper_content)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "3ac1dabb-884d-4bd7-9ce3-edd08f6c9e35",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[1672, 1652, 27171, 2627, 46819]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[len(i) for i in papers]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "6a9ab051-ac79-4050-93d9-7008b5074ed6",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Case Report: HGF and NF1 mutations as putative bypass mechanisms of MET inhibitor resistance in hepatocellular carcinoma: a case study.',\n",
       " 'Background: Hepatocellular carcinoma (HCC) is a highly aggressive liver cancer with poor prognosis, often associated with resistance to treatment. MET amplification has been identified as a potential therapeutic target, but resistance to MET inhibitors, such as crizotinib, remains a significant challenge. This study aims to explore the molecular mechanisms underlying resistance to MET inhibitors in MET-amplified HCC. Methods: We present a case of advanced HCC in a patient with MET amplification treated with crizotinib. After initial tumor regression, disease progression occurred. Genetic',\n",
       " 'challenge. This study aims to explore the molecular mechanisms underlying resistance to MET inhibitors in MET-amplified HCC. Methods: We present a case of advanced HCC in a patient with MET amplification treated with crizotinib. After initial tumor regression, disease progression occurred. Genetic analysis using next-generation sequencing (NGS) was performed on biopsy samples taken before and after progression to identify mutations associated with resistance. Results: NGS revealed the loss of MET amplification and identified HGF and NF1 mutations as potential bypass mechanisms. Specifically,',\n",
       " 'analysis using next-generation sequencing (NGS) was performed on biopsy samples taken before and after progression to identify mutations associated with resistance. Results: NGS revealed the loss of MET amplification and identified HGF and NF1 mutations as potential bypass mechanisms. Specifically, a missense mutation in HGF (p.G401A) was observed, which may enhance ligand-receptor binding, while an NF1 mutation (p.M546L) may permit sustained MAPK and PI3K activation despite MET inhibition. These observations are preliminary and require validation in larger patient cohorts. Conclusion: Our',\n",
       " 'a missense mutation in HGF (p.G401A) was observed, which may enhance ligand-receptor binding, while an NF1 mutation (p.M546L) may permit sustained MAPK and PI3K activation despite MET inhibition. These observations are preliminary and require validation in larger patient cohorts. Conclusion: Our findings suggest that acquired resistance to MET inhibitors in MET-amplified HCC may involve clonal evolution and activation of compensatory signaling pathways. These insights highlight the need for dynamic molecular surveillance and the development of strategies targeting multiple pathways to',\n",
       " 'Our findings suggest that acquired resistance to MET inhibitors in MET-amplified HCC may involve clonal evolution and activation of compensatory signaling pathways. These insights highlight the need for dynamic molecular surveillance and the development of strategies targeting multiple pathways to overcome resistance and improve patient outcomes.']"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "splited = split_text_into_chunks(papers[1], chunk_size=600,\n",
    "                                             chunk_overlap=300)\n",
    "splited"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ac23d300-fc62-407f-8265-409a50f8a216",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "False\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[[{'name': 'Crizotinib treatment effectiveness',\n",
       "   'value': 'initial tumor regression followed by disease progression',\n",
       "   'source_id': [2],\n",
       "   'cited_blocks': ['challenge. This study aims to explore the molecular mechanisms underlying resistance to MET inhibitors in MET-amplified HCC. Methods: We present a case of advanced HCC in a patient with MET amplification treated with crizotinib. After initial tumor regression, disease progression occurred. Genetic analysis using next-generation sequencing (NGS) was performed on biopsy samples taken before and after progression to identify mutations associated with resistance. Results: NGS revealed the loss of MET amplification and identified HGF and NF1 mutations as potential bypass mechanisms. Specifically,']}],\n",
       " [{'name': 'Crizotinib effectiveness',\n",
       "   'value': 'More sensitive to low-risk group',\n",
       "   'source_id': [5],\n",
       "   'cited_blocks': ['performed in risk groups. Expression of signature genes in CRC cells was examined using quantitative reverse transcription polymerase chain reaction (qRT-PCR). There were 10 CRC-related RRAGs found. Prognostic models were built with RRAGs. Based on immune infiltration analysis, low-risk populations showed significantly greater levels of immune infiltration (P P ARHGEF17 mutation rate was 6%. Medications such as CGP-082996, Dasatinib, Erlotinib, and Salubrinal were more sensitive to high-risk group, whereas drugs such as FTI-277, DMOG, and Crizotinib were more sensitive to low-risk group.']}],\n",
       " [{'name': 'Crizotinib effectiveness',\n",
       "   'value': 'NP',\n",
       "   'source_id': [],\n",
       "   'cited_blocks': []}],\n",
       " [{'name': 'main_results_crizotinib',\n",
       "   'value': 'no objective responses observed in RASMT advanced CRC patients',\n",
       "   'source_id': [7],\n",
       "   'cited_blocks': ['with low baselineÂ\\xa0KRASMT allele frequency. CONCLUSIONS: Combination binimetinib/crizotinib showed a poor tolerability with no objective responses observed in RASMT advanced CRC patients. EudraCT-Number: 2014-000463 -â\\x80\\x8940 (20/06/2014: A Sequential Phase I study of MEK1/2 inhibitors PD- 0325901 or Binimetinib combined with cMET inhibitor Crizotinib in RAS Mutant and RAS Wild Type with aberrant c-MET).']}],\n",
       " [{'name': 'Crizotinib_effectiveness',\n",
       "   'value': 'selectively inhibited the growth of ARID1A-deficient CRC cells',\n",
       "   'source_id': [80, 142],\n",
       "   'cited_blocks': ['validated the synthetic lethal effect of the c-MET inhibitor PHA-665752 (PHA) in two ARID1A knockout (ARID1A-KO) clones, where PHA selectively inhibited the growth of ARID1A-KO HCT116 cells (Fig.Â\\xa01D). Moreover, two FDA-approved c-MET inhibitors, crizotinib, and cabozantinib, also showed synthetic lethality in ARID1A-KO HCT116 clones (Fig.Â\\xa01E, F). These results suggest that c-MET is a potential synthetic lethal target for ARID1A in CRC cells.',\n",
       "    'synthetic lethality in ARID1A-deficient CRC. Notably, FDA-approved c-MET inhibitors, such as crizotinib and cabozantinib, have demonstrated enhanced cytotoxicity in ARID1A-deficient cancers, facilitating the translation of these approved drugs for repurposing in ARID1A-targeted precision cancer medicine.']}]]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "api = StudyCharacteristicsExtraction()\n",
    "extracted = api.run(\n",
    "    papers=papers,\n",
    "    fields=['Results, string, main results of the study regarding Crizotinib, usually about treatment effectiveness'],#api.DEFAULT_FIELDS,\n",
    "    llm='Qwen/Qwen3-32B',#\"openai-gpt-4o\",\n",
    "    chunk_size=600,\n",
    "    chunk_overlap=300,\n",
    "    thinking=False,\n",
    ")\n",
    "extracted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "dc85b6da-8fe9-4484-8430-e55e239b2525",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[{'name': 'Crizotinib effectiveness',\n",
       "   'value': 'More sensitive to low-risk group',\n",
       "   'source_id': [4],\n",
       "   'cited_blocks': ['performed in risk groups. Expression of signature genes in CRC cells was examined using quantitative reverse transcription polymerase chain reaction (qRT-PCR). There were 10 CRC-related RRAGs found. Prognostic models were built with RRAGs. Based on immune infiltration analysis, low-risk populations showed significantly greater levels of immune infiltration (P P ARHGEF17 mutation rate was 6%. Medications such as CGP-082996, Dasatinib, Erlotinib, and Salubrinal were more sensitive to high-risk group, whereas drugs such as FTI-277, DMOG, and Crizotinib were more sensitive to low-risk group.']}],\n",
       " [{'name': 'Crizotinib treatment effectiveness',\n",
       "   'value': 'initial tumor regression followed by disease progression',\n",
       "   'source_id': [1],\n",
       "   'cited_blocks': ['challenge. This study aims to explore the molecular mechanisms underlying resistance to MET inhibitors in MET-amplified HCC. Methods: We present a case of advanced HCC in a patient with MET amplification treated with crizotinib. After initial tumor regression, disease progression occurred. Genetic analysis using next-generation sequencing (NGS) was performed on biopsy samples taken before and after progression to identify mutations associated with resistance. Results: NGS revealed the loss of MET amplification and identified HGF and NF1 mutations as potential bypass mechanisms. Specifically,']}]]"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "80601546-e32e-4b65-b837-b5dec0abdfc4",
   "metadata": {},
   "outputs": [],
   "source": [
    "llm_reasoning = ChatOpenAI(\n",
    "    base_url=BASE_URL,\n",
    "    api_key=HUGGINGFACE_HUB_TOKEN,\n",
    "    model=MODEL_NAME_HF,\n",
    "    streaming=True,\n",
    "    temperature=0,\n",
    "    #http_client=httpx_client\n",
    "    http_async_client=httpx.AsyncClient(verify=False)\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "87efd589-f082-4326-bc29-42ab4cd01c9a",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<think>\n",
      "\n",
      "</think>\n",
      "\n",
      "```json\n",
      "[\n",
      "    {\n",
      "        \"name\": \"Crizotinib effectiveness\",\n",
      "        \"value\": \"More sensitive to low-risk group\",\n",
      "        \"source_id\": [3]\n",
      "    }\n",
      "]\n",
      "```\n"
     ]
    }
   ],
   "source": [
    "prompt = ChatPromptTemplate.from_messages([\n",
    "    (\"user\", '/no_think {text}'),\n",
    "    # (\"ai\", \"Good.\")\n",
    "])\n",
    "\n",
    "chain = prompt | llm_reasoning\n",
    "response = await chain.ainvoke({\"text\": ff})\n",
    "\n",
    "#fin_condition = response.content.strip('<think>\\n\\n</think>\\n\\n')\n",
    "print(response.content)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:llms]",
   "language": "python",
   "name": "conda-env-llms-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.14.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
